SPOREs : Current SPORE Programs : Head and Neck

Organization of the Organ Systems Branch
Overview, organization, staff listing and contact information

Current SPORE Programs
Abstracts and Cores of currently funded SPOREs

Information for the Public
Information for the public interested in activities of the SPORE program and frequently asked questions

PART Program
Information about the Patient Advocate Research Team Program

Information for Applicants
Information for researchers interested in applying for the SPORE program

IntraSPORE Communications
(access restricted to SPORE Investigators)

[ SPOREs: Brain | Breast | GI | GU | GYN | Head and Neck | Leukemia | Lung | Lymphoma | Myeloma | Ovarian | Pancreatic | Prostate | Skin ]

Head and Neck SPOREs

SPOREs in Head and Neck Cancer support translational research on cancers of the upper aerodigestive tract and on thyroid cancer. An estimated 37,800 patients will be diagnosed for cancers of the oral cavity, pharynx, or larynx in the year 2002. In another 20,700 patients thyroid cancer will be detected. The incidence rate for the first group of cancers is 2 to 3 times higher in men as in women, with the highest rate in male over the age of 40, whereas thyroid cancer is three times more common in women as in men. By the estimates of the American Cancer Society, 11,100 people will die of cancers of the oral cavity, pharynx, or larynx and 1,300 of thyroid cancer. The SPORE program introduced SPOREs in Head and Neck Cancers in the year 2001 with the result of three new SPOREs being funded in the year 2002. New solicitations are planned in years 2003 and 2005.

To view the associated abstract, click on the name/address below.

Clinical Trials

The page is maintained by: Website Contact